Healios K.K. (OTCMKTS:HLOSF) Sees Large Increase in Short Interest

Healios K.K. (OTCMKTS:HLOSF) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 13,100 shares, a growth of 2,083.3% from the January 15th total of 600 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Healios K.K. Price Performance

Shares of HLOSF stock opened at $0.96 on Thursday. Healios K.K. has a 12-month low of $0.93 and a 12-month high of $1.73. The stock’s 50-day moving average price is $1.12 and its 200-day moving average price is $1.34.

About Healios K.K.

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.